Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Berberine Hydrochloride: Novel Pathways in Ferroptosis and A
2026-07-02
Explore how Berberine Hydrochloride modulates ferroptosis and inflammation through AMPK and Nrf2/SLC7A11/GPX4 signaling. This article offers advanced insights for metabolic disease and acute kidney injury research, setting it apart from standard Berberine reviews.
-
HyperScript™ Reverse Transcriptase: Precision cDNA for Compl
2026-07-02
HyperScript™ Reverse Transcriptase, engineered from M-MLV, enables robust cDNA synthesis from low-copy and structurally challenging RNA—empowering transcriptomic studies where conventional enzymes fail. Its thermal stability and high affinity make it indispensable for applications like qPCR and RNA-Seq in animal welfare research and beyond.
-
Staurosporine: Broad-Spectrum Kinase Inhibitor for Cancer Re
2026-07-01
Staurosporine stands as a gold-standard broad-spectrum serine/threonine protein kinase inhibitor, enabling robust apoptosis induction and kinase pathway interrogation across diverse cancer research workflows. This guide details actionable protocols, advanced applications, and troubleshooting insights, positioning APExBIO's Staurosporine as an indispensable tool for high-impact preclinical studies.
-
TRPV1/TRPA1 Activation Triggers TSLP Release in Nasal Epithe
2026-07-01
This study demonstrates that TRPV1 and TRPA1 channels on nasal epithelial cells directly mediate the secretion of TSLP and other inflammatory cytokines via a Ca2+/NFAT pathway. These findings clarify the molecular basis of upper airway inflammation and provide actionable insights for membrane transporter and sensory neuron ion channel research.
-
CPSIT_0844 from Chlamydia psittaci Triggers Monocyte Inflamm
2026-06-30
This study identifies CPSIT_0844, an inclusion membrane protein from Chlamydia psittaci, as a potent inducer of IL-6 and IL-8 in human monocytes through TLR2/TLR4-MyD88 signaling. The work delineates the molecular pathways that underpin inflammatory responses in C. psittaci infection and broadens our understanding of host-pathogen interactions in inflammatory signaling pathway research.
-
Bradford Protein Assay Kit: Technical Guidance for Reliable
2026-06-30
The Bradford Protein Assay Kit (SKU: K4103) enables rapid, sensitive protein concentration measurements in research workflows demanding minimal sample volume and fast turnaround. It is ideal for routine biochemical protein assays in molecular biology, purification, and enzyme studies, but is not recommended for samples containing high concentrations of interfering detergents or proteins with very low arginine or aromatic content.
-
Applied Strategies with 5-(N,N-dimethyl)-Amiloride Hydrochlo
2026-06-29
Harness the selectivity of 5-(N,N-dimethyl)-Amiloride hydrochloride to dissect Na+/H+ exchanger signaling in translational research. This guide delivers actionable workflows, troubleshooting insights, and a synthesis of new biomarker findings to empower robust endothelial injury and cardiac dysfunction assays.
-
Talabostat Mesylate (PT-100): DPP4 and FAP Inhibition in Can
2026-06-29
Talabostat mesylate (PT-100) is a potent, orally active inhibitor of dipeptidyl peptidases DPP4 and FAP. It modulates tumor microenvironment and enhances immune response, with verified activity in both in vitro and in vivo cancer research models.
-
Palmitic acid (Hexadecanoic Acid): Technical Guidance & QC
2026-06-28
Palmitic acid (SKU N2456) provides a high-purity, well-characterized saturated long-chain fatty acid for research focusing on lipid metabolism, protein palmitoylation, and metabolic disorder mechanisms. It is not suitable for aqueous-based assays or protocols requiring long-term solution stability, making precise preparation and immediate use essential for reproducible outcomes.
-
ddhCTP in Antiviral Research: Protocols & Workflow Innovatio
2026-06-27
Leverage ddhCTP (3ʹ-deoxy-3′,4ʹ-didehydro-CTP) to precisely inhibit viral RNA synthesis and dissect RNA virus replication mechanisms in advanced cell-based assays. This guide translates cutting-edge viperin biology into stepwise protocols, practical troubleshooting, and strategic assay design for translational antiviral research.
-
IP6 Enhances Oxaliplatin Sensitivity in HCC via CCN2-LRP6-AB
2026-06-26
This study demonstrates that inositol hexaphosphate (IP6) improves the anti-tumor efficacy of oxaliplatin in hepatocellular carcinoma (HCC) by inhibiting the CCN2-LRP6-β-catenin-ABCG1 signaling axis. These results elucidate a key mechanism of oxaliplatin resistance and suggest new strategies for optimizing platinum-based chemotherapeutic regimens in HCC.
-
Canagliflozin and Mitochondrial Bioenergetics in Renal Disea
2026-06-26
Explore how Canagliflozin, a potent SGLT2 inhibitor, drives mitochondrial remodeling and bioenergetic improvement in diabetic kidney models. This article offers advanced insights for diabetes and renal research, setting a new benchmark in SGLT2 inhibitor applications.
-
Precision Cell Viability Assays: Bridging Mechanism and Stra
2026-06-25
This thought-leadership article explores the mechanistic basis and translational impact of advanced mammalian cell viability assays, spotlighting the Live-Dead Cell Staining Kit I (Calcein AM/PI). We integrate recent oncology findings, protocol guidance, and competitive analysis to provide actionable insights for translational researchers seeking to optimize experimental rigor and clinical relevance.
-
Pazopanib (GW-786034): Strategic Angiogenesis Inhibition in
2026-06-25
This article provides translational researchers with a deep mechanistic overview and strategic guidance on leveraging Pazopanib (GW-786034) for advanced cancer research, highlighting its value in ATRX-deficient tumors, experimental workflows, and future directions in precision oncology.
-
Polyphosphazene Nanoparticle Crosslinking with Spermine Tetr
2026-06-24
This study demonstrates how spermine tetrahydrochloride enables the formation of protein-loaded ionic polyphosphazene nanoparticles through ionic crosslinking, preserving protein integrity and modulating cellular interactions. The findings offer valuable insights for researchers developing advanced protein delivery systems and nanoparticle-based therapeutic formulations.